{"id":"W1986004507","doi":"10.1158/0008-5472.sabcs-4115","title":"Activity and safety of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: initial results from a phase II study.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Tolerability; Medicine; Metastatic breast cancer; Trastuzumab; Taxane; Internal medicine; Sunitinib; Dosing; Breast cancer; Clinical endpoint; Lapatinib; Placebo; Oncology; Pharmacology; Adverse effect; Cancer; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002930597,0.001507532,0.003039352,0.0004475449,0.0004178976,0.001024687,0.0009421549,0.001232269,0.004123412],"category_scores_gemma":[0.001252186,0.0005867464,0.001583515,0.0005107847,0.0008194365,0.0009685608,0.0002770392,0.002084242,0.0008504081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009618721,"about_ca_system_score_gemma":0.001359501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008365964,"about_ca_topic_score_gemma":0.001909879,"domain_scores_codex":[0.9991887,0.0004321493,0.00005312321,0.0001116591,0.00008418201,0.0001300847],"domain_scores_gemma":[0.9990309,0.0002091481,0.0002446901,0.00006891909,0.00006337974,0.0003828829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7052094,0.07453036,0.009249967,0.001736828,0.002946402,0.0004851954,0.0003907136,0.002399108,0.05420608,0.0001524878,0.003844038,0.1448495],"study_design_scores_gemma":[0.3697475,0.6002105,0.02120177,0.00006995889,0.001001183,0.0005481187,0.0000599652,0.0008941535,0.003537996,0.0001190513,0.002576046,0.00003366952],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897648,0.005477169,0.0005452728,0.0002897159,0.00008257593,0.001499121,0.0007807493,0.00008854779,0.001472048],"genre_scores_gemma":[0.9904078,0.003303929,0.0009647795,0.0004700471,0.0002061773,0.001268384,0.001812291,0.00004016259,0.001526623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004123412,"threshold_uncertainty_score":0.01549864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1784208525827542,"score_gpt":0.5111586758417982,"score_spread":0.332737823259044,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}